Introduction
Quality assurance/control of radiotherapy treatments is vital for the patient safety. In this study, we are utilizing the hardware of Tomotherapy machines to investigate the feasibility of using exit detector signal to perform quality assurance of Tomotherapy treatments. Inter-and intrafraction variations associated with patient anatomical changes and setup errors may alter the intended dose distribution.
Methods
Tomotherapy has developed Delivery Verification software (DVTool) described by Kapatoes et al. [1] [2] [3] [4] in which exit detector data stored within the patient's record is used to reconstruct the dose distribution on a fraction-by-fraction basis. The software uses a GPU platform which reconstructs the dose in ~3 minutes. The DV-Tool uses the exit detector data sinogram to reconstruct the delivery sinogram and subsequently computes dose distributions in kilo-voltage CT (kVCT) or daily mega-voltage CT (MVCT) datasets. This tool was used by Sheng et al. 5 , in which the patient's kVCT dataset was used in the dose reconstructions to eliminate variations caused by the anatomical changes and setup of the patient. His results showed the reconstructed dose distributions were within a tolerance of ±5%. In our study we have tested the robustness of this tool using a liquid water female body phantom to verify the consistency and sensitivity in detecting anatomical changes (weight loss) and setup errors. Two treatment plans mimicking a breast and gynecological treatment plans, created on the phantoms, were used in this study. To check the delivery consistency of the DV Tool, both plans were delivered 20 times over 2 months. Weight loss simulations were done on the gynecological plan while the setup error simulations were done on the breast plan. Weight loss simulations were created by placing eight layers of 5 mm bolus to the pelvis of the phantom (Figure 1 ). The treatment plan only allowed the radiation beams to enter through the bolus. After delivering a fraction, a layer of bolus was removed, MVCT images were taken with no registration applied, and another fraction was delivered. This was continued until all bolus was removed. To analyze the machine consistency and weight loss simulations, a scaling factor was applied to the reconstructed DVH to match the PTV mean dose to the plan. The scaling factors were than adjusted for the machine output. To simulate a setup error, the breast phantom was shifted at known distance from the origin, MVCT images were taken with no registration applied, and another fraction was delivered at the shifted position. This was performed for ±3, ±5, and ±10 mm in the x and z direction (laterally and vertically, respectively). Planning CT images along with the RT-structures, and reconstructed dose matrix with the shifted MVCT image-sets were exported to a third party analysis software, Computational Environment for Radiotherapy Research (CERR), for further analysis. When the MVCT image is registered with the planning kVCT image, the reconstructed dose matrix is co-registered with the kVCT and therefore, planning structures can be used for dose volume computations/metrics. The reconstructed doses volume indices were analyzed by comparing them against plan.
Results
The machine delivery consistency check of the gynecological plans revealed that the deviations were greater (±5%) during the week just prior to target replacement which was reflected in the dose reconstructions. After output adjustments, the deviations for the breast and gynecological plans agreed within ±1.0% and ±2.5%, respectively (Figure 2) . The larger deviation shown in the gynecological plan is attributed to forcing the entrance beam to only pass through the limited area of the bolus. The weight loss simulation on gynecological plan showed a strong correlation (R 2 =0.998) between lost thickness and increasing PTV mean dose by approximately 5%/cm (Figure 3) . Setup errors on the breast plan showed broadening shoulder of the PTV-DVH for shifts greater than 5mm. Volume at 20Gy for the right lung increased by 6% for 10mm shifts in both x and z directions. The dose volume indices differences are given in Table 1 .
Conclusion
This phantom study supports the feasibility of using exit detector data for in vivo quality assurance for helical tomotherapy treatments. The results show that the DV Tool was sensitive to anatomical changes, setup errors, and machine output and characteristics. The weight loss simulations suggest that patients may need to be re-simulated if they have lost 1-2 cm of tissue at the treatment site. The setup errors data concludes that as the phantom is shifted, the PTV dose conformity decreases while potentially increasing dose to lungs and heart depending on the direction and distance of the shift. Using exit detector data with the DV Tool has the potential to monitoring the patient's delivered treatments. 
